NasdaqGM - Delayed Quote • USD
Tactile Systems Technology, Inc. (TCMD)
At close: April 23 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 4 | 4 | 4 |
Avg. Estimate | -0.11 | 0.11 | 0.57 | 0.93 |
Low Estimate | -0.18 | 0.07 | 0.56 | 0.84 |
High Estimate | -0.04 | 0.15 | 0.58 | 1.06 |
Year Ago EPS | -0.09 | 0 | 1.23 | 0.57 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 59.17M | 73.1M | 302.9M | 343.39M |
Low Estimate | 59M | 72.2M | 302.5M | 339.7M |
High Estimate | 59.5M | 74.3M | 303.6M | 350.07M |
Year Ago Sales | 58.85M | 68.34M | 274.42M | 302.9M |
Sales Growth (year/est) | 0.60% | 7.00% | 10.40% | 13.40% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.24 | -0.05 | 0.03 | 0.19 |
EPS Actual | -0.09 | 0 | 0.94 | 0.35 |
Difference | 0.15 | 0.05 | 0.91 | 0.16 |
Surprise % | 62.50% | 100.00% | 3,033.30% | 84.20% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.11 | 0.11 | 0.57 | 0.93 |
7 Days Ago | -0.11 | 0.11 | 0.57 | 0.93 |
30 Days Ago | -0.11 | 0.11 | 0.57 | 0.93 |
60 Days Ago | -0.11 | 0.11 | 0.57 | 0.93 |
90 Days Ago | -0.06 | 0.12 | 0.52 | 0.98 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
CURRENCY IN USD | TCMD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -22.20% | -- | -- | 0.40% |
Next Qtr. | -- | -- | -- | 9.90% |
Current Year | -53.70% | -- | -- | 4.30% |
Next Year | 63.20% | -- | -- | 13.40% |
Next 5 Years (per annum) | 5.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | 27.85% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Oppenheimer: Outperform to Outperform | 8/8/2023 |
Maintains | Oppenheimer: Outperform | 5/9/2023 |
Maintains | Piper Sandler: Overweight | 5/9/2023 |
Maintains | BTIG: Buy | 4/17/2023 |
Maintains | Oppenheimer: Outperform | 8/2/2022 |
Maintains | Piper Sandler: Overweight | 8/2/2022 |
Related Tickers
TMCI Treace Medical Concepts, Inc.
10.86
-2.16%
CTKB Cytek Biosciences, Inc.
5.81
+0.17%
AXGN AxoGen, Inc.
6.97
+1.60%
CNMD CONMED Corporation
71.31
-1.79%
AORT Artivion, Inc.
20.78
+2.26%
KIDS OrthoPediatrics Corp.
30.63
+1.42%
SRDX Surmodics, Inc.
26.92
+6.03%
ELMD Electromed, Inc.
16.39
+4.26%
SMLR Semler Scientific, Inc.
27.09
+3.16%
ARAY Accuray Incorporated
2.2200
+2.30%